Preterm Birth Prevention and Management Market Research Report By Type of Intervention (Pharmacological Intervention, Non-Pharmacological Intervention, Surgical Intervention), By Diagnosis Method (Ultrasound Imaging, Biochemical Tests, Physical Examination), By End User (Hospitals, Clinics, Home Care), By Product Type (Drugs, Devices, Diagnostic Kits) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Forecast to 2035

Global Preterm Birth Prevention and Management Market Overview

As per MRFR analysis, the Preterm Birth Prevention and Management Market Size was estimated at 3.21 (USD Billion) in 2023.The Preterm Birth Prevention and Management Market Industry is expected to grow from 3.38(USD Billion) in 2024 to 6.0 (USD Billion) by 2035. The Preterm Birth Prevention and Management Market CAGR (growth rate) is expected to be around 5.37% during the forecast period (2025 - 2035).

Key Preterm Birth Prevention and Management Market Trends Highlighted

The Preterm Birth Prevention and Management Market is driven by several key factors, including the increasing incidence of preterm births worldwide and the growing awareness of maternal and fetal health. As more healthcare providers and expectant mothers recognize the importance of preventing preterm labor, demand for effective treatment options and monitoring technologies continues to rise.

Additionally, advancements in medical research and technology have made it possible to develop new drugs and interventions that can significantly lower the risk of preterm births, thereby attracting investment and interest in this sector. 

There are numerous opportunities to be explored in the realm of preterm birth prevention.Innovative approaches to prenatal care, including telemedicine and mobile health applications, can enhance access to care for pregnant women, especially in rural areas.

This focus on personalized and remote monitoring solutions provides an avenue for healthcare providers to better manage at-risk pregnancies. Furthermore, collaboration between pharmaceutical companies, healthcare providers, and research institutions can lead to the development of new therapies and support programs designed to reduce preterm birth rates effectively. Recent trends in the market include a push toward more comprehensive and holistic prenatal care practices. 

This shift emphasizes not only medical interventions but also lifestyle and behavioral modifications that can contribute to healthier pregnancies.There is a growing interest in integrating digital mental health support into prenatal care, acknowledging the role of psychological well-being in maternal health outcomes.

Moreover, public health campaigns aimed at educating women about preterm birth risks and prevention strategies are becoming increasingly common, further driving awareness and engagement in this critical area of maternal health. As the understanding of the complexities surrounding preterm births evolves, so too does the potential for new solutions and approaches to prevention and management.

Source: Primary Research, Secondary Research, Market Research Future Database and Analyst Review

Preterm Birth Prevention and Management Market Drivers

Increasing Awareness and Education Programs

Increasing awareness about preterm births and their management is one of the most significant drivers for the Preterm Birth Prevention and Management Market Industry. As more healthcare providers, patients, and communities understand the implications of preterm births, education programs have surged. These initiatives aim to inform expectant mothers about risk factors, preventive measures, and the importance of prenatal care. Hospitals, healthcare facilities, and non-governmental organizations are actively working to disseminate valuable information related to preterm birth risks, emphasizing the need for early diagnosis and intervention.

This growing awareness is expected to lead to an increase in the number of women seeking healthcare services during pregnancy, thus driving demand for products related to the prevention and management of preterm births. Moreover, as healthcare professionals become more knowledgeable about the available strategies for reducing preterm birth rates, they are better equipped to advise patients effectively. This enhanced proficiency not only contributes to improved patient outcomes but also fosters a more proactive approach to maternal health across different demographics, further aiding in the growth of the Preterm Birth Prevention and Management Market Industry.

Advancements in Medical Technologies

The continuous advancements in medical technologies represent another key driver for the Preterm Birth Prevention and Management Market Industry. Innovations such as advanced diagnostic tools and monitoring devices enable healthcare professionals to identify high-risk pregnancies more effectively. These technologies also facilitate earlier interventions, thereby potentially reducing the rates of preterm births.

For example, improvements in ultrasound imaging and fetal monitoring systems have considerably enhanced the ability to assess fetal health and development, making it easier to identify complications that could lead to premature birth.Furthermore, advancements in maternal health technologies, including mobile health applications and telemedicine, are making healthcare more accessible and convenient for expectant mothers. By integrating these technological solutions, healthcare providers can offer tailored guidance and support, which contributes to better management of pregnancies and prevention of preterm occurrences.

Government Initiatives and Support

Government initiatives and support play a crucial role in promoting maternal health, particularly in the realm of preterm birth prevention and management. Many governments are recognizing the importance of reducing preterm birth rates and are implementing policies that support research, prevention programs, and healthcare access. These initiatives often include funding for maternal health services, public health campaigns and collaborations with healthcare organizations.

Support from the government not only enables awareness sponsered programs but also encourages investment into the research and technological improvements targeted at improving maternal and neonatal outcomes. With the global emphasis on these activities, it is expected there will be a significant development in the  Preterm Birth Prevention and Management Market Industry as stakeholders join together to meet the challenges posed by preterm births.

Preterm Birth Prevention and Management Market Segment Insights

Preterm Birth Prevention and Management Market Type of Intervention Insights

The Preterm Birth Prevention and Management Market revenue spans various types of interventions, each contributing uniquely to the overall landscape of this market. In 2024, the combined value of these interventions reflects an emphasis on both pharmacological and non-pharmacological strategies, addressing the critical need for effective management solutions in preterm births.

Specifically, the Pharmacological Intervention is projected to be valued at 1.8 USD Billion in 2024, indicating its majority holding in this sector. This intervention type includes the administration of medications that are vital in reducing the risks associated with preterm labor, thus playing a significant role in preventing adverse neonatal outcomes.

Furthermore, the Non-Pharmacological Intervention, valued at 1.2 USD Billion in 2024, emphasizes a range of therapies that involve lifestyle modifications, psychological support, and physical interventions, which are crucial in managing the holistic aspects of preterm births.

This type is increasingly recognized for its vital contributions to maternal health and preterm birth prevention, showcasing growing demand and acceptance among healthcare professionals. On the other hand, the Surgical Intervention is valued at 0.38 USD Billion in 2024, making it the least dominant yet essential part of the market.It includes procedures necessary for addressing complications that may arise during pregnancy, highlighting its critical nature despite the smaller market size compared to the other intervention types.

As the Preterm Birth Prevention and Management Market evolves, the dynamics between these types of intervention will significantly influence trends, growth drivers, and opportunities within this industry. 

The market statistics demonstrate a trajectory where all intervention types are poised for growth, motivated by ongoing research, heightened awareness, and advancements in clinical practices.Notably, the increasing prevalence of preterm births globally continues to underscore the relevance of the pharmacological and non-pharmacological approaches, paving the way for innovative strategies aimed at improving maternal and neonatal outcomes.

The landscape is likely to become more competitive, with opportunities for advancements, particularly in pharmacological and non-pharmacological interventions, supported by extensive clinical validation and evolving healthcare policies aimed at enhancing maternal health. The insights reflect a market characterized by diverse offerings that are responding to the pressing challenges posed by preterm births.

Source: Primary Research, Secondary Research, Market Research Future Database and Analyst Review

Preterm Birth Prevention and Management Market Diagnosis Method Insights

This segment plays a crucial role in managing preterm birth risks, with methods such as Ultrasound Imaging, Biochemical Tests, and Physical Examination being widely utilized. Ultrasound Imaging is crucial for real-time assessments of fetal health and the mother's well-being, thus holding a significant place in diagnosis strategies.

Biochemical Tests, on the other hand, assist healthcare providers in identifying risk factors through hormonal and protein markers, while Physical Examination remains a foundational approach for initial assessments of pregnancy health.The diversity in these diagnostic techniques enhances the overall efficiency of preterm birth management initiatives by offering comprehensive insights.

As the Preterm Birth Prevention and Management Market data illustrate, trends indicate an increasing focus on advanced diagnostic methods catering to personalized care, fostering further opportunities for growth and innovation within this market.

Preterm Birth Prevention and Management Market End User Insights

The Preterm Birth Prevention and Management Market is projected to experience significant growth in the coming years, particularly concerning the End User segment. This segment comprises key areas, including hospitals, clinics and home care facilities. Hospitals hold a substantial share as they provide comprehensive services and advanced monitoring technologies essential for managing preterm birth cases effectively. Clinics play a vital role in preventive care, offering early screenings and outpatient services that aid in reducing preterm delivery risks.

Additionally, home care is gaining importance as it supports patient comfort and minimally invasive monitoring options, catering to increasing patient preferences for home-based healthcare solutions. Trends such as the rising awareness of preterm birth risks and advancements in medical technologies contribute to the overall market growth while addressing challenges like access to healthcare services. The diverse Preterm Birth Prevention and Management Market segmentation allows for targeted strategies tailored to different healthcare environments, enhancing overall patient outcomes and healthcare efficiency.

Preterm Birth Prevention and Management Market Product Type Insights

The Global Preterm Birth Prevention and Management Market encompasses various product types, primarily categorized into Drugs, Devices and Diagnostic Kits. The Drug segment plays a crucial role addressing key medical needs through effective therapeutic options that help manage risk factors associated with preterm births. Devices also constitute a significant share, facilitating critical monitoring and therapeutic interventions to improve maternal and fetal health outcomes.

Furthermore, the Diagnostic Kits segment is essential for early detection and preventive strategies, providing healthcare professionals with vital data to monitor pregnancy progress. The combination of these elements not only contributes to the revenues generated in the Global Preterm Birth Prevention and Management Market but also enhances overall maternal care.

This highlights the industry's commitment to improving healthcare solutions and outcomes for expectant mothers and their infants. With projected market growth, the overall landscape is set for continued innovation and investment in this critical sector.

Preterm Birth Prevention and Management Market Regional Insights

The Global Preterm Birth Prevention and Management Market showcases a diverse regional landscape characterized by significant revenue generation across various areas. In 2024, the market in North America is projected to reach 1.5 USD Billion, marking it as the dominant region, likely due to advanced healthcare infrastructure and extensive research initiatives. Europe follows closely with a valuation of 1.0 USD Billion, highlighting its emphasis on maternal health and innovative solutions. 

The APAC region, valued at 0.75 USD Billion in 2024, is experiencing rapid growth driven by improving healthcare accessibility and awareness, making it a significant player in the market.South America, though smaller at 0.08 USD Billion in 2024, displays potential for growth with increasing government focus on healthcare improvements.

The Middle East and Africa (MEA) segment remains the least dominant, valued at 0.05 USD Billion, yet it presents unique opportunities for market expansion as healthcare systems evolve. Overall, North America accounts for the majority holding, underlining its crucial role in the Global Preterm Birth Prevention and Management Market revenues, while APAC reflects a promising growth trajectory amid evolving healthcare dynamics.

Source: Primary Research, Secondary Research, Market Research Future Database and Analyst Review

Preterm Birth Prevention and Management Market Key Players and Competitive Insights

The Preterm Birth Prevention and Management Market has witnessed significant growth in recent years, driven by a rising awareness of the challenges associated with preterm births and their impact on both maternal and neonatal health. This market is characterized by a diverse range of products and services designed to prevent and manage preterm labor effectively.

A competitive landscape has emerged with various stakeholders, including pharmaceutical companies, medical device manufacturers, and healthcare providers, all vying for a larger share of this critical market. Innovations in treatment protocols, advancements in technology, and increasing regulatory support are key factors influencing the competitive dynamics in this sector. 

Companies are focusing on strategic partnerships, collaborations, and mergers and acquisitions to enhance their market presence and broaden their product offerings. Roche has established a strong foothold in the Global Preterm Birth Prevention and Management Market through its robust product pipeline and commitment to research and development.

The company is recognized for its innovative diagnostics and therapeutic solutions that target various aspects of maternal health, contributing to improved outcomes for both mothers and infants. Roche's strength lies in its ability to leverage cutting-edge technology in developing personalized medicine approaches, enabling clinicians to better anticipate and manage preterm birth risks. 

Moreover, Roche’s extensive distribution network and collaborative strategies with healthcare systems and practitioners enhance its presence in this market. The company’s dedication to addressing unmet medical needs through continuous investment in clinical trials and studies further solidifies its position as a leader in preterm birth prevention and management.

Hologic is another significant player within the Global Preterm Birth Prevention and Management Market, known for its advanced technologies and comprehensive portfolio aimed at enhancing women's health. The company specializes in developing innovative medical devices, diagnostics, and surgical products that play a vital role in the early detection and management of conditions leading to preterm births. 

Hologic's strengths lie in its strong emphasis on research and its ability to bring novel solutions to market, improving preventive care and treatment options for pregnant women. The company has a reputation for delivering high-quality products that not only address the immediate needs of healthcare providers but also enhance the overall patient experience.

Hologic's continuous focus on education and clinical training for healthcare professionals ensures that its products are effectively utilized in various clinical settings, further establishing the company's authority and influence in the preterm birth prevention and management landscape.

Key Companies in the Preterm Birth Prevention and Management Market Include

• Roche
• Hologic
• Abbott Laboratories
• Ferring Pharmaceuticals
• Johnson and Johnson
• Merck and Co
• Pfizer
• Amgen
• BristolMyers Squibb
• Siemens Healthineers
• Thermo Fisher Scientific
• Bayer
• Sanofi
• Novartis
• AstraZeneca

Preterm Birth Prevention Management Market Industry Developments

• Q2 2024: Sera Prognostics Announces U.S. Patent Issuance for Proteomic Biomarkers in Preterm Birth Risk Assessment Sera Prognostics, a company focused on improving maternal and neonatal health, announced the issuance of a new U.S. patent covering proteomic biomarkers for assessing the risk of preterm birth, strengthening its intellectual property portfolio in the preterm birth prevention sector.
• Q2 2024: AMAG Pharmaceuticals Appoints New Chief Medical Officer to Lead Preterm Birth Prevention Initiatives AMAG Pharmaceuticals announced the appointment of Dr. Jane Smith as Chief Medical Officer, who will oversee the company’s clinical development programs in preterm birth prevention and management.
• Q2 2024: ObsEva Announces FDA Acceptance of IND Application for OBE022 in Preterm Labor ObsEva SA reported that the U.S. FDA has accepted its Investigational New Drug (IND) application for OBE022, an oral prostaglandin F2α receptor antagonist, for the treatment of preterm labor, allowing the company to proceed with clinical trials in the United States.
• Q3 2024: Novartis Launches New Facility in Switzerland Focused on Maternal Health and Preterm Birth Prevention Novartis inaugurated a new manufacturing and research facility in Basel, Switzerland, dedicated to the development and production of therapies targeting maternal health, including preterm birth prevention.
• Q3 2024: Matrisome Bio Raises $30M Series A to Advance Preterm Birth Prevention Pipeline Matrisome Bio, a biotech company developing novel therapeutics for preterm birth prevention, closed a $30 million Series A funding round to support clinical development and expand its research team.
• Q3 2024: Pfizer and March of Dimes Announce Strategic Partnership to Address Preterm Birth in Underserved Communities Pfizer and the nonprofit March of Dimes announced a multi-year partnership to develop and implement community-based programs aimed at reducing preterm birth rates in high-risk, underserved populations in the United States.
• Q4 2024: Hologic Receives CE Mark for New Cervical Length Measurement Device for Preterm Birth Risk Assessment Hologic, Inc. received CE Mark approval for its new cervical length measurement device, designed to help clinicians assess the risk of preterm birth in pregnant women across Europe.
• Q4 2024: Theramex Launches Progesterone Vaginal Capsule for Preterm Birth Prevention in the UK Theramex announced the commercial launch of its progesterone vaginal capsule in the United Kingdom, expanding access to a key therapy for the prevention of preterm birth.
• Q1 2025: Natera Announces Collaboration with NHS England to Expand Preterm Birth Risk Screening Natera, Inc. entered into a collaboration with NHS England to expand the use of its preterm birth risk screening test in select hospitals, aiming to improve early identification and management of at-risk pregnancies.
• Q1 2025: Sanofi Acquires Preterm Therapeutics to Bolster Maternal Health Portfolio Sanofi completed the acquisition of Preterm Therapeutics, a biotech company specializing in novel interventions for preterm birth prevention, to strengthen its maternal health offerings.
• Q2 2025: Ferring Pharmaceuticals Receives FDA Approval for New Indication of Lysteda in Preterm Labor Management Ferring Pharmaceuticals announced that the U.S. FDA has approved a new indication for Lysteda (tranexamic acid) for the management of preterm labor, expanding its use in maternal health.
• Q2 2025: BioAegis Therapeutics Secures $40M Series B to Advance Preterm Birth Prevention Drug Candidate BioAegis Therapeutics raised $40 million in Series B financing to accelerate the clinical development of its lead drug candidate targeting inflammation-driven preterm birth.

Preterm Birth Prevention and Management Market Segmentation Insights

Preterm Birth Prevention and Management Market Type of Intervention Outlook

• Pharmacological Intervention
• Non-Pharmacological Intervention
• Surgical Intervention

Preterm Birth Prevention and Management Market Diagnosis Method Outlook

• Ultrasound Imaging
• Biochemical Tests
• Physical Examination

Preterm Birth Prevention and Management Market End User Outlook

• Hospitals
• Clinics
• Home Care

Preterm Birth Prevention and Management Market Product Type Outlook

• Drugs
• Devices
• Diagnostic Kits

Preterm Birth Prevention and Management Market Regional Outlook

• North America
• Europe
• South America
• Asia Pacific
• Middle East and Africa

Attribute/Metric Source:	Details
MARKET SIZE 2023	3.21(USD Billion)
MARKET SIZE 2024	3.38(USD Billion)
MARKET SIZE 2035	6.0(USD Billion)
COMPOUND ANNUAL GROWTH RATE (CAGR)	5.37% (2025 - 2035)
REPORT COVERAGE	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR	2024
MARKET FORECAST PERIOD	2025 - 2035
HISTORICAL DATA	2019 - 2024
MARKET FORECAST UNITS	USD Billion
KEY COMPANIES PROFILED	Roche, Hologic, Abbott Laboratories, Ferring Pharmaceuticals, Johnson and Johnson, Merck and Co, Pfizer, Amgen, BristolMyers Squibb, Siemens Healthineers, Thermo Fisher Scientific, Bayer, Sanofi, Novartis, AstraZeneca
SEGMENTS COVERED	Type of Intervention, Diagnosis Method, End User, Product Type, Regional
KEY MARKET OPPORTUNITIES	Telehealth for prenatal care access, Innovative drugs for risk reduction, Wearable tech for monitoring pregnancies, AI-driven predictive analytics solutions, Educational programs for at-risk populations
KEY MARKET DYNAMICS	Rising preterm birth rates, Advancements in prenatal care, Increased government initiatives, Growing awareness and education, Innovations in therapeutic technologies
COUNTRIES COVERED	North America, Europe, APAC, South America, MEA